Edwards Lifesciences Corporation (FRA:EWL)

Germany · Delayed Price · Currency is EUR

65.89

-0.20 (-0.30%)

At close: Oct 23, 2025

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
Transcatheter Aortic Valve Replacement Revenue	4.24B	4.11B	Log In	Log In	Log In	Upgrade
Transcatheter Mitral and Tricuspid Therapies Revenue	445.90M	352.10M	Log In	Log In	Log In	Upgrade
Surgical Structural Heart Revenue	1.00B	981.30M	Log In	Log In	Log In	Upgrade
Critical Care Revenue	-	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	5.69B	5.44B	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2011 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2011 - 2020
United States Revenue	3.35B	3.21B	Log In	Log In	Log In	Upgrade
Europe Revenue	1.38B	1.32B	Log In	Log In	Log In	Upgrade
Japan Revenue	344.40M	339.80M	Log In	Log In	Log In	Upgrade
Rest of World Revenue	611.10M	572.00M	Log In	Log In	Log In	Upgrade
Revenue (Total)	5.69B	5.44B	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.